BRCA1 cooperates in the Fanconi anemia/BRCA1 pathway.

Slides:



Advertisements
Similar presentations
P53 The Master Guardian of the Genome. p53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
Advertisements

V Dissecting the cellular response to DNA breaks using functional genomics Ásta Björk Jónsdóttir, Paul Russell, Alessandro Esposito, Tamara Gruener, Ashok.
Fanconi Anemia (FA) Rare, inherited chromosome instability disorder –Originally described by Guido Fanconi in 1927 Patients have diverse congenital abnormalities.
Investigating the BRCA1 Mutation F.R.E.S.H Docs. Angelina Jolie Actress, Film director, and Screenwriter Mother had Breast Cancer and died at 56 from.
Fanconi Anemia & FANCD2
P53 The Master Guardian. R point Cell cycle control involves several checkpoints and checkpoint (molecular breaking) mechanisms.
FANCD2 FANCONI ANEMIA PROTEIN COMPLEMENTATION GROUP D2 by Meredith Binkley.
BRCA Genes Dallas Henson.
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
Jeopardy Jeopardy General Sex Determination in humans Mendelian Genetics Non-Mendelian Genetics DNA Replication and Recombination
Blood Cancer & Chromosome 21 By Manasi Shah. Core Binding Factor Acute Myeloid Leukemia (CBF-AML) AML is a type of cancer that affects bone marrow and.
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
Sigma-aldrich.com/cellsignaling Hypothetical Model on the Functions of the WRN, BLM and MRE11.
DNA Replication S phase of Interphase. DNA Replication DNA Replication DNA Replication occurs during the S phase of the INTERPHASE. STEP 1: Separation.
Ch. 12: Inheritance Patterns & Human Genetics. 18 things you pretty much already know about genetics L6Y
BRCA2: Breast Cancer Susceptibility Gene 2 Lindy Behrend March 4, 2003.
FANCD2 & the Fanconi Anemia Tumor Suppressor Pathway Shayna Purcell Joo et al., 333 (6040):
Fanconi Anemia Anthony Winchell. What is Fanconi Anemia?
Breast Cancer Ten percent of breast cancer is hereditary. Or 23,000 women a year with a genetic basis for their cancer. The most common mutations in this.
Role of the p21 Protein in the Fanconi Anemia (FA) Pathway
Two RING finger proteins mediate cooperation between ubiquitin ‐ conjugating enzymes in DNA repair by Helle D. Ulrich, and Stefan Jentsch EMBO J. Volume.
Susceptibility to Inheritance
Karyotyping Cancer.
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
Fanconi Anemia and Laron Syndrome
and its role in FA and other Cancers
Targeting the DNA Damage Response in Cancer
breast cancer 2, early onsetpro What does this protein make up or do?
Regulation of the Cell Cycle & Cancer
FANCD2: Fanconi Anemia and Cancer
FANCD2 and Fanconi’s Anemia
Chromosomal Landscapes
Individualizing Care in Ovarian Cancer
Chk1 and Chk2 kinases in checkpoint control and cancer
RNA ACTIVE FIGURE General features of a replication fork ACTIVE FIGURE General features of a replication fork. The DNA duplex is unwound.
Chromosomal Landscapes
George-Lucian Moldovan, Alan D. D'Andrea  Cancer Cell 
Oh what a tangled web it weaves: BRCA1 and DNA decatenation
 MISMATCH REPAIR: corrects mistakes when DNA is copied
Figure 1 Putative anticancer mechanisms of action of PARP inhibitors
Volume 47, Issue 1, Pages (July 2012)
DNA-Mismatch Repair: The intricacies of eukaryotic spell-checking
FANCF methylation contributes to chemoselectivity in ovarian cancer
Fanconi anemia pathway
Fungal BRCA2 Ortholog Brh2 Brings 5′ End Strand Invasion Back on Stage
Volume 137, Issue 2, Pages (May 2015)
DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2  Katharina Schlacher, Hong Wu, Maria Jasin 
Zoran Z Zdraveski, Jill A Mello, Martin G Marinus, John M Essigmann 
Volume 3, Issue 4, Pages (April 2003)
DNA Mismatch Repair: Dr. Jekyll and Mr. Hyde?
Lucas T. Gray, Alan M. Weiner  Molecular Cell 
(A) Poly(ADP-ribosyl)ation often referred to as PARylation is a post-translational protein modification catalyzed by poly(ADP-ribose) polymerases [PARPs].
Andrew J. Deans, Stephen C. West  Molecular Cell 
DNA DSB repair signaling pathways through the apical DDR kinases.
Activated membrane signaling promotes survival in response to radiation. Activated membrane signaling promotes survival in response to radiation. Radiation.
Fanconi Anemia (Cross)linked to DNA Repair
The DNA Damage Response: Making It Safe to Play with Knives
Specific Tumor Suppressor Genes
The DNA Damage Response: Making It Safe to Play with Knives
Volume 35, Issue 5, Pages (September 2009)
Proposed model for the role of PALB2 in linking BRCA1 with BRCA2 and RAD51 in a pathway of HR. We propose that BRCA1 binds to the NH2 terminus of PALB2.
TGF-β Pathway Inhibition Signals New Hope for Fanconi Anemia
Effects of PARP inhibition on the DNA damage response.
Association between BRCA1 transcript level and cisplatin sensitivity, BRCA1 promoter methylation, and NtAI. Association between BRCA1 transcript level.
FANCD2 Hurdles the DNA Interstrand Crosslink
Predicted pathogenic BRCA1 amino acid substitutions are confined to the evolutionarily conserved N- and C-terminal domains. Predicted pathogenic BRCA1.
Genomic instability is a core feature of ovarian cancer that frequently involves DNA-damage repair genes. Genomic instability is a core feature of ovarian.
Cooperation of the FA and BRCA1/2 proteins in a common ICL repair pathway. Cooperation of the FA and BRCA1/2 proteins in a common ICL repair pathway. Stalling.
Volume 3, Issue 4, Pages (April 2003)
Presentation transcript:

BRCA1 cooperates in the Fanconi anemia/BRCA1 pathway. BRCA1 cooperates in the Fanconi anemia/BRCA1 pathway. The fifteen known Fanconi anemia proteins (A, B, C, D1, D2, E, F, G, I, J, L, M, N, O, P) cooperate in a common DNA repair pathway (green). The pathway is activated when a replication fork stalls at a cisplatin interstrand cross-link (ICL). The Fanconi anemia core complex binds to the stalled fork, leading to monoubiquitination and recruitment of the I and D2 proteins. The downstream Fanconi anemia proteins (D2, N, J, and O) are recruited to DNA repair complexes. Additional proteins (red), while not bona fide Fanconi anemia proteins, are also required for function of the Fanconi anemia pathway and for repair of DNA cross-links. The BRCA1 protein is a Fanconi anemia-like protein and binds in a complex with at least 3 bonafide Fanconi anemia proteins. Biallelic mutations in BRCA1 (see text) result in an inherited ovarian cancer (Fanconi anemia-like) syndrome. Alan D. D'Andrea Cancer Discovery 2013;3:376-378 ©2013 by American Association for Cancer Research